Enzyme regulation phosphorylation

FIGURE 15.2 Enzymes regulated by covalent modification are called interconvertible enzymes. The enzymes protein kinase and protein phosphatase, in the example shown here) catalyzing the conversion of the interconvertible enzyme between its two forms are called converter enzymes. In this example, the free enzyme form is catalytically active, whereas the phosphoryl-enzyme form represents an inactive state. The —OH on the interconvertible enzyme represents an —OH group on a specific amino acid side chain in the protein (for example, a particular Ser residue) capable of accepting the phosphoryl group. 

The first is cell injury (cytotoxicity), which can be severe enough to result in cell death. There are many mechanisms by which xenobiotics injure cells. The one considered here is covalent binding to cell macromol-ecules of reactive species of xenobiotics produced by metabolism. These macromolecular targets include DNA, RNA, and protein. If the macromolecule to which the reactive xenobiotic binds is essential for short-term cell survival, eg, a protein or enzyme involved in some critical cellular function such as oxidative phosphorylation or regulation of the permeability of the plasma membrane, then severe effects on cellular function could become evident quite rapidly. 

One main line of future research could be in the inhibitory/activating effect on key enzymes involved in the pathogenesis of arteriosclerosis. In particular, enzymes regulating signal transduction involved in phosphorylation of proteins, such as PKC and tyrosine protein kinase, seems to be somehow modulated by different polyphenols and may represent a possible target for polyphenol activity. 

TABLE 23-3 Examples of proteins regulated by phosphorylation Enzymes involved in neurotransmitter biosynthesis Tyrosine hydroxylase Tryptophan hydroxylase Neurotransmitter receptors Adrenergic receptors Dopamine receptors Opioid receptors Glutamate receptors Many others... 

An understanding of the molecular basis for regulation of isocitrate dehydrogenase by phosphorylation was facilitated by X-ray crystallography of the phosphorylated enzyme in complex with isocitrate. The crystal structures of mutants of the enzyme in which SerllS had been exchanged for aspartate or glutamate were also solved (Hurley et al., 1990). The structure of the enzyme in complex with the substrate isocitrate revealed the phophorylation site to be localized near isocitrate. SerllS itself binds the substrate directly via a H-bond with the O of isocitrate (fig. 2.13). 

One enzyme regulated by AMPK is acetyl-CoA carboxylase, which produces malonyl-CoA, the first intermediate committed to fatty acid synthesis. Malonyl-CoA is a powerful inhibitor of the enzyme carnitine acyl-transferase I, which starts the process of ]3 oxidation by transporting fatty acids into the mitochondrion (see Fig. 17-6). By phosphorylating and inactivating acetyl-CoA carboxylase, AMPK inhibits fatty acid synthesis while relieving the inhibition (by malonyl-CoA) of )3 oxidation (Fig. 23-37). 

Regulation of acetyl-CoA carboxylase by phosphorylation and dephosphorylation. Glucagon is known to activate cAMP-dependent protein kinase this kinase phosphorylates both serine 77 and serine 1200 of rat acetyl-CoA carboxylase, which inactivates the enzyme. However, there is also an AMP-dependent kinase that phosphorylates serine 79 and serine 1200 and inactivates the rat acetyl-CoA carboxylase. The relative importance of these two kinases in regulating the carboxylase in vivo is still unclear. Likewise, the phosphorylated enzyme is a substrate for several different protein phosphate phosphatases, and the physiologically relevant phosphatases are not known. Epinephrine may inhibit the carboxylase via a Ca2+-dependent protein kinase. 

JH Hurley, P Thorsness, V Ramalingham, N Helmers, DE Koshland Jr, RM Stroud. Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase. Proc Natl Acad Sci (USA) 86 8635-8639, 1989. 

All the major biosynthetic pathways use acetyl-CoA as the basic building block, and in each pathway the rate limiting enzyme is regulated by phosphorylation with the phosphorylated enzyme being active. In the biosynthesis of cholesterol, the rate limiting step is catalyzed by hydroxymethylglutaryl-CoA (HMG-CoA) reductase. Initially, three molecules of acetyl-CoA are condensed to produce /5-HMG-CoA. HMG-CoA reductase then uses two NADPH molecules to reduce HMG-CoA to mevalonate-CoA. The remaining steps in cholesterol biosynthesis are numerous and well-documented. 

Boyd, G.S. and Gorban, A.M.S. (1980) In Recently Discovered Systems of Enzyme Regulation by Reversible Phosphorylation (Cohen. P.. ed.) p. 95. Elsevier/North Holland Biomedical Press, Amsterdam. 

Two key regulatory enzymes involved in the control of glycogen metabolism were first recognized as targets of cAMP and cAMP-dependent protein kinase in liver and skeletal muscle. These are phosphorylase b kinase and glycogen synthase. The molecular details of the phosphorylation and regulation of these enzymes are better understood in muscle than in liver since the liver enzymes have only recently been purified to homogeneity in the native form. However, it appears that they share many key features in common. 

Figure 7-2. Reactions of the pyruvate dehydrogenase (PDU) multienzyme complex (PDC). Pyruvate is decarboxylated by the PDH subunit (I ,) in the presence of thiamine pyrophosphate (TPP). The resulting hydroxyethyl-TPP complex reacts with oxidized lipoamide (LipS3), the prosthetic group of dehydrolipoamide transacetylase (Ii2), to form acetyl lipoamide. In turn, this intermediate reacts with coenzyme A (CoASH) to yield acetyl-CoA and reduced lipoamide [Lip(SH)2]. The cycle of reaction is completed when reduced lipoamide is reoxidized by the flavoprotein, dehydrolipoamide dehydrogenase (E3). Finally, the reduced flavoprotein is oxidized by NAD+ and transfers reducing equivalents to the respiratory chain via reduced NADH. PDC is regulated in part by reversible phosphorylation, in which the phosphorylated enzyme is inactive. Increases in the in-tramitochondrial ratios of NADH/NAD+ and acetyl-CoA/CoASH also stimulate kinase-mediated phosphorylation of PDC. The drug dichloroacetate (DCA) inhibits the kinase responsible for phosphorylating PDC, thus locking the enzyme in its unphosphory-lated, catalytically active state. Reprinted with permission from Stacpoole et al. (2003).

Protein phosphorylation dephosphorylation regulates the activity of enzymic and nonenzymic proteins in eukaryotic cells. Ten per cent or more of all proteins in a cell are modified in that way. The phosphates are transferred from ATP and esterified with hydroxyl groups of serine, threonine, or tyrosine residues. They are removed and transferred to water by phosphatases. There are at least about 2000 kinases and about 1000 phosphatases to carry out these reactions (Fig. 7.1). ... 

We turn now to a different mechanism of enzyme regulation. Many enzymes acquire full enzymatic activity as they spontaneously fold into their characteristic three-dimensional forms. In contrast, other enzymes are synthesized as inactive precursors that are subsequently activated by cleavage of one or a few specific peptide bonds. The inactive precursor is called a zymogen (or a proenzyme). A energy source (ATP) is not needed for cleavage. Therefore, in contrast with reversible regulation by phosphorylation, even proteins located outside cells can be activated by this means. 

---